Your session is about to expire
← Back to Search
Paravertebral Block Analgesia for Pain Management
Study Summary
This trialwill compare the safety and pain control of two methods of analgesia after hepatectomy.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
May I be considered for inclusion in this medical experiment?
"Candidates for this clinical study must have pain under control after elective hepatectomy and be aged between 18 and 80. A total of 50 people are required to participate in the trial."
Are individuals over fifty years of age eligible for this clinical research?
"In order to be considered for this experiment, individuals must fall between the age-range of 18 and 80."
What are the main aims of this clinical trial?
"This 30-minute clinical assessment will track pain levels, as well as the total volume of vasopressors and fluids administered during surgery and up to 72 hours after. Additionally, central venous pressure measurements will be taken throughout the trial period."
Is Paravertebral Block Analgesia a secure approach to pain relief?
"Our team at Power rated Paravertebral Block Analgesia's safety a 3, as this Phase 4 clinical trial indicates that the treatment is approved."
What is the upper limit on enrolment for this experiment?
"Affirmative. The information accessible through clinicaltrials.gov verifies that this research trial, which was initially published on April 1st 2016, is presently seeking volunteers. Specifically, 50 individuals are needed from one medical site."
Is enrollment still open for this clinical trial?
"Affirmative. According to the clinical trial listing, this experiment began on April 1st 2016 and was recently updated on December 2nd 2022. At present, 50 patients are being sought from one medical centre."
Share this study with friends
Copy Link
Messenger